Adenocarcinoma
|
group |
Neoplasms
|
Neoplastic Process
|
2235
|
168
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Adult Medulloblastoma
|
disease |
Neoplasms
|
Neoplastic Process
|
762
|
24
|
0.010 |
None |
1.000 |
1 |
|
2005 |
2005 |
Age at menarche
|
phenotype |
Behavior and Behavior Mechanisms
|
Finding
|
267
|
591
|
0.100 |
None |
1.000 |
2 |
2
|
2014 |
2019 |
Amphetamine Abuse
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
75
|
|
0.300 |
None |
1.000 |
1 |
|
2008 |
2008 |
Amphetamine Addiction
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
81
|
2
|
0.300 |
None |
1.000 |
1 |
|
2008 |
2008 |
Amphetamine-Related Disorders
|
group |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
78
|
3
|
0.300 |
None |
1.000 |
1 |
|
2008 |
2008 |
Amyotrophic Lateral Sclerosis
|
disease |
Nutritional and Metabolic Diseases; Nervous System Diseases
|
Disease or Syndrome
|
1114
|
485
|
0.030 |
None |
1.000 |
3 |
|
2017 |
2019 |
androgen independent prostate cancer
|
disease |
|
Neoplastic Process
|
190
|
5
|
0.010 |
None |
1.000 |
1 |
|
2005 |
2005 |
Anxiety
|
disease |
Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
1048
|
287
|
0.010 |
None |
1.000 |
1 |
1
|
2014 |
2014 |
Anxiety Disorders
|
group |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
840
|
163
|
0.010 |
None |
1.000 |
1 |
1
|
2014 |
2014 |
Body mass index
|
phenotype |
|
Clinical Attribute
|
1014
|
2689
|
0.100 |
None |
1.000 |
14 |
9
|
2010 |
2019 |
Body mass index procedure
|
phenotype |
|
Diagnostic Procedure
|
88
|
252
|
0.100 |
None |
1.000 |
4 |
3
|
2010 |
2014 |
Body Weight
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Organism Attribute
|
57
|
92
|
0.300 |
None |
1.000 |
1 |
|
2012 |
2012 |
Breast Carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6776
|
2793
|
0.050 |
None |
1.000 |
5 |
|
2002 |
2018 |
Carcinogenesis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6243
|
355
|
0.070 |
None |
1.000 |
7 |
|
2003 |
2017 |
Carcinomatosis
|
phenotype |
Neoplasms
|
Neoplastic Process
|
186
|
2
|
0.010 |
None |
1.000 |
1 |
|
2004 |
2004 |
Cavernous Hemangioma of Brain
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms; Nervous System Diseases; Hemic and Lymphatic Diseases; Cardiovascular Diseases
|
Anatomical Abnormality
|
127
|
43
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Cervical Intraepithelial Neoplasia
|
disease |
Neoplasms
|
Neoplastic Process
|
398
|
29
|
0.010 |
None |
1.000 |
1 |
|
2007 |
2007 |
Cervical Squamous Intraepithelial Neoplasia
|
disease |
Pathological Conditions, Signs and Symptoms; Neoplasms; Female Urogenital Diseases and Pregnancy Complications
|
Neoplastic Process
|
109
|
3
|
0.010 |
None |
1.000 |
1 |
|
2007 |
2007 |
Childhood Leukemia
|
disease |
Neoplasms
|
Neoplastic Process
|
1740
|
140
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Childhood Medulloblastoma
|
disease |
Neoplasms
|
Neoplastic Process
|
771
|
25
|
0.010 |
None |
1.000 |
1 |
|
2005 |
2005 |
Cholelithiasis
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
252
|
90
|
0.010 |
None |
1.000 |
1 |
1
|
2017 |
2017 |
Chronic kidney disease stage 5
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
666
|
194
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Colon Carcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
2832
|
275
|
0.020 |
None |
1.000 |
2 |
|
2015 |
2016 |
Colorectal Carcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
5473
|
1962
|
0.020 |
None |
1.000 |
2 |
2
|
2012 |
2016 |